Atlas Trials

Prospective Evaluation of Xerava Prophylaxis in Hematological Malignancy Patients With Prolonged Neutropenia

Clinical trial NCT05537896 · RECRUITING

Trial details

NCT number
NCT05537896
Sponsor
West Virginia University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Hematological MalignancyNeutropenia
Start date
2024-02-19
Primary completion
2028-02-01
Enrollment
55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.